Diagnosis of pathologies of mononucleated blood cells
CA 2387560 A1 · Owner: Assistance Publique Hopitaux De Paris · Inventors: Barritault, Denis; Baudouin, Francoise; Achour, Ammar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method which uses the growth factor HARP to detect mononucleated blood cells and which provides a means of diagnosing the proliferative pathologies of this type of cell such as chronic lymphoid leukaemia. The method for detecting the B lymphocytes comprises bringing a blood sample and some HARP polypeptide a fragment or a derivative of HARP into contact with each other and detecting the fixation of the HARP polypeptide fragment or derivative of HARP to the surface of the B lymphocytes. The method for diagnosing proliferative pathologies of mononucleated blood cells also comprises the comparison of the rates of fixation of HARP to the B lymphocytes of a sample from …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 6, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.